NMS · Biotechnology

RXRX (RXRX) Stock

$3.05 +1.33% NMS: RXRX Healthcare

Valuation

MetricValue
Price$3.05
Market Cap$1.60B
P/E Ratio-3.91
P/B Ratio1.78
P/S Ratio27.49
EPS (TTM)$-0.90
52-Week High$7.18
52-Week Low$2.77
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-57.16%
ROA-27.66%
ROCE-57.29%
Gross Margin-864.00%
Operating Margin-19.86%
Net Margin-860.00%
Debt/Equity0.07
Current Ratio5.47

Annual Financials (USD)

Metric20212022202320242025
Revenue$10.0M$40.0M$45.0M$59.0M$75.0M
Operating Profit$-183.0M$-246.0M$-350.0M$-479.0M$-648.0M
Net Profit$-186.0M$-239.0M$-328.0M$-464.0M$-645.0M
EPS$-1.49$-1.36$-1.58$-1.69$-1.44
Op Margin-1796.0%-617.0%-785.0%-814.0%-868.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$610.0M$701.0M$654.0M$1.4B$1.5B
Total Liabilities$67.0M$215.0M$190.0M$414.0M$343.0M
Cash$285.0M$550.0M$392.0M$594.0M$743.0M
Borrowings$1.0M$1.0M$1.0M$1.0M$1.0M

Latest News

Why Recursion Pharmaceuticals (RXRX) Outpaced the Stock Market Today Zacks · Jul 14, 2026 Cathie Wood Is Loading Up on This Biotech Stock. Is It a No-Brainer Buy? Motley Fool · Jul 14, 2026 2 Beaten-Down Stocks That Still Aren't Worth Buying Motley Fool · Jul 11, 2026 Is Recursion Pharmaceuticals (RXRX) The Best Penny Stocks According to Billioanires? Insider Monkey · Jul 9, 2026 Here's Why Recursion Pharmaceuticals (RXRX) Fell More Than Broader Market Zacks · Jul 8, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-159.0M$-84.0M$-288.0M$-359.0M$-372.0M
Investing Cash Flow$-272.0M$193.0M$-10.0M$260.0M$-17.0M
Financing Cash Flow$459.0M$154.0M$140.0M$304.0M$522.0M
Net Cash Flow$28.0M$264.0M$-158.0M$205.0M$133.0M
Free Cash Flow$-198.0M$-121.0M$-300.0M$-373.0M$-378.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-2.47
FCF Yield-20.70%
Quick Ratio5.15
Interest Coverage—
Return 1Y-53.19%
Return 3Y-78.92%
Return 5Y-89.72%

Ownership

Insiders Held2.37%
Institutions Held68.85%
Institutions Float Held70.52%
Institutional HolderSharesReport Date
Blackrock Inc.43,192,3062026-03-31
ARK Investment Management, LLC40,212,7692026-03-31
State Street Corporation28,490,6382026-03-31
BAILLIE GIFFORD & CO23,675,4072026-03-31
Vanguard Portfolio Management LLC22,759,1002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AGIO $31.72 +0.38% -3.56 $1.89B 0.00%
BEAM $25.62 +2.19% -35.36 $2.64B 0.00%
COGT $42.27 -1.33% -34.70 $7.22B 0.00%
DNLI $24.42 +1.03% -6.20 $3.88B 0.00%
ETNB89bio, Inc. $14.84 +0.00% -12.82 $2.20B 0.00%

About RXRX

RXRX stock trades at $3.05 with a market capitalization of $1.60B. The stock is valued at a price-to-earnings (P/E) ratio of -3.91, price-to-book of 1.78, price-to-sales of 27.49. Over the past 52 weeks the stock has ranged between $2.77 and $7.18, and currently trades 57.5% below its 52-week high.

On profitability, RXRX generates a return on equity (ROE) of -57.16%, return on capital employed of -57.29%, an operating margin of -19.86%, a net profit margin of -860.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides